The Annual Diabetes and Cancer Interface Symposium: Connecting the Dots

The Annual Diabetes and Cancer Interface Symposium: Connecting the Dots

Diabetes and cancer are two of the major health scourges of the 21st century. Driven by interactions between genetics and the environment, these are diseases of metabolic disruption that greatly burden our lives. Research is focused on disease classification, prevention and treatment strategies that are tailored to the molecules and pathways that are dysregulated in affected individuals.

City of Hope is a unique organization with dual foci on cancer and diabetes that increasingly applies molecular tools at the interfaces of overweight, obesity, carcinogenesis, diabetogenesis and complications of treatments. The Arthur Riggs Diabetes & Metabolism Research Institute, is pleased to sponsor the annual Connecting the Dots Symposium, which brings together researchers and clinicians who are building expertise along the interfaces.

The fourth annual Connecting the Dots Symposium will take place virtually on Tuesday, November 14, 2023, from 8 a.m. to 1 p.m. PST.

Submit your abstract below to be considered for a 20 to 40-minute talk at the symposium. Deadline to submit an abstract is October 13, 2023.

Please click the registration button below to attend the virtual symposium and opt-in for future announcements.

Please email with any questions or to opt-out of receiving emails.

Thank you for your interest in the interfaces between diabetes and cancer!

Charles Brenner, Ph.D.
Alfred E. Mann Family Foundation Chair in Diabetes and Cancer Metabolism
Professor and Chair, Department of Diabetes & Cancer Metabolism

Debbie C. Thurmond, Ph.D.
Chan Soon-Shiong Shapiro Distinguished Chair in Diabetes
Director, Arthur Riggs Diabetes & Metabolism Research Institute at City of Hope
Professor, Department of Molecular & Cellular Endocrinology